• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

As FDA decision nears, GSK projects 'Shingrix-like' sales for its RSV vaccine...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Apr 26, 2023 at 05:52: PM
via GSK, homing in on a potential world-first vaccine approval in respiratory syncytial virus (RSV), figures its candidate could eventually net billions of dollars each year, executives said Wednesday.

article source
 

<



Similar threads

cafead
Merck&#039;s Keytruda hits overall survival goal in early lung cancer as FDA decision nears
Replies
0
Views
91
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Orchard nears FDA decision on rare disease gene therapy
Replies
0
Views
71
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Bluebird touts Zynteglo, Skysona launch progress as FDA decision on sickle cell therapy nears
Replies
0
Views
196
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA decision on preterm birth drug’s withdrawal nears, putting spotlight on patients, agency
Replies
0
Views
176
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA decision nears on Aimmune&#039;s contested peanut allergy drug
Replies
0
Views
166
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote